newsfilter
← Latest News
ACCESS Newswire·

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025

- Reports Net Revenues of $174.4 million for the Three Months Ended June 30, 2025- GAAP net income of $31.0 million, or $0.64 per share, for the second quarter- Adjusted non-GAAP net income of $40.9 million, or $0.85 per